1 / 17

TRIAL NAME

TRIAL NAME. Presenter NAME. Article Reference. Picture of trial. DEFINE the TRIAL ACRONYM. BACKGROUND. Key points Key points Points about why trial was made. ADD PICTURE HERE. Clinical question. WHAT IS THE CLINICAL QUESTION OF TRIAL?. PICTURE. DESIGN . Analysis:

baxter-haynes
Télécharger la présentation

TRIAL NAME

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. TRIAL NAME Presenter NAME Article Reference

  2. Picture of trial DEFINE the TRIALACRONYM

  3. BACKGROUND • Key points • Key points • Points about why trial was made • ADD PICTURE HERE

  4. Clinical question WHAT IS THE CLINICAL QUESTION OF TRIAL? • PICTURE

  5. DESIGN • Analysis: • Where was it performed? • N= ? • Group 1 • Group 2 • Setting: • Median follow-up: ? • Primary outcome: __ • Secondary outcomes: __

  6. Population Inclusion Criteria Exclusion Criteria Contraindication to anticoagulation therapy Ineligible to undergo trials of ≥2 medications in either treatment strategy • Key Points

  7. Interventions • Group 1 • DESCRIBE • Group 2 (Placebo Control) • Describe • Any other key points re: interventions?

  8. RESULTS

  9. RESULTS

  10. criticisms • Criticism 1 • Criticism 2 • Criticism 3

  11. Bottom line ONE LINER ON TAKE AWAY POINTS

  12. Discussion questions • Discussion question 1 • Discussion question 2 • Discussion question 3

  13. Discussion ANSWERS • Discussion question 1 • ANSWER: _ • Discussion question 2 • ANSWER: _ • Discussion question 3 • ANSWER: _

  14. BOARD-LIKE Question 70 yo male __ PE: Labs: Imaging: (Adapted from MKSAP) QUESTION What/When/Where/Who/Why_? • _ • _ • _ • _

  15. BOARD-LIKE Question QUESTION What/When/Where/Who/Why_? • _ • _ • _ • _ Educational Objective: _ Key Point: • Point 1 • Point 2

  16. CLINICAL PEARL • Changes in guideline? • How to apply to daily practice?

  17. REFERENCES

More Related